{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:08:30Z","timestamp":1709791710048},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T00:00:00Z","timestamp":1288828800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/2047-783x-15-s2-60","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T02:52:11Z","timestamp":1576032731000},"source":"Crossref","is-referenced-by-count":4,"title":["Pulmonary lesions and serum levels of soluble Fas (sCD95) in former hard coal miners"],"prefix":"10.1186","volume":"15","author":[{"given":"F.","family":"Hoffmeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Borowitzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Merget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"B\u00fcnger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Raulf-Heimsoth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,4]]},"reference":[{"key":"527_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ACI.0b013e32802bf8a5","volume":"7","author":"F Huaux","year":"2007","unstructured":"Huaux F: New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin immunol 2007, 7: 168\u201373. 10.1097\/ACI.0b013e32802bf8a5","journal-title":"Curr Opin Allergy Clin immunol"},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1055\/s-2007-980153","volume":"61","author":"F Hoffmeyer","year":"2007","unstructured":"Hoffmeyer F, van Kampen V, Br\u00fcning T, Merget R: Pneumoconiosis. Pneumologie 2007, 61: 774\u201393. (Article in German) 10.1055\/s-2007-980153","journal-title":"Pneumologie"},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1582-4934.2004.tb00318.x","volume":"8","author":"GA DosReis","year":"2004","unstructured":"DosReis GA, Borges VM, Zin WA: The central role of Fas-ligand cell signaling in inflammatory lung diseases. J Cell Mol Med 2004, 8: 285\u201393. 10.1111\/j.1582-4934.2004.tb00318.x","journal-title":"J Cell Mol Med"},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2249.1997.d01-901.x","volume":"107","author":"S Jodo","year":"1997","unstructured":"Jodo S, Kobayashi S, Kayagaki N, Ogura N, Feng Y, Amasaki Y, Fujisaku A, Azuma M, Yagita H, Okumura K, Koike T: Serum levels of soluble Fas\/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immunol 1997, 107: 89\u201395. 10.1046\/j.1365-2249.1997.d01-901.x","journal-title":"Clin Exp Immunol"},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1126\/science.7510905","volume":"263","author":"J Cheng","year":"1994","unstructured":"Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994, 263: 1759\u201362. 10.1126\/science.7510905","journal-title":"Science"},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2249.1997.tb08332.x","volume":"110","author":"A Tomokuni","year":"1997","unstructured":"Tomokuni A, Aikoh T, Matsuki T, Isozaki Y, Otsuki T, Kita S, Ueki H, Kusaka M, Kishimoto T, Ueki A: Elevated soluble Fas\/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin exp immunol 1997, 110: 303\u20139.","journal-title":"Clin exp immunol"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1046\/j.1365-2567.1998.00509.x","volume":"94","author":"T Otsuki","year":"1998","unstructured":"Otsuki T, Sakaguchi H, Tomokuni A, Aikoh T, Matsuki T, Kawakami Y, Kusaka M, Ueki H, Kita S, Ueki A: Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 1998, 94: 258\u201362. 10.1046\/j.1365-2567.1998.00509.x","journal-title":"Immunology"},{"key":"527_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/153537020623100506","volume":"231","author":"T Otsuki","year":"2006","unstructured":"Otsuki T, Miura Y, Nishimura Y, Hyodoh F, Takata A, Kusaka M, Katsuyama H, Tomita M, Ueki A, Kishimoto T: Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol Med 2006, 231: 522\u201333.","journal-title":"Exp Biol Med"},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.mcp.0000152998.11335.24","volume":"11","author":"B Rimal","year":"2005","unstructured":"Rimal B, Greenberg AK, Rom WN: Basic pathogenetic mechanisms in silicosis: Current understanding. Curr Opin Pulm Med 2005, 11: 169\u201373. 10.1097\/01.mcp.0000152998.11335.24","journal-title":"Curr Opin Pulm Med"},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1164\/ajrccm.157.5.9707141","volume":"157","author":"BT Mossman","year":"1998","unstructured":"Mossman BT, Churg A: Mechanisms in the pathogenesis of asbestosis and silicosis. Am J respir Crit Care Med 1998, 157: 1666\u201380.","journal-title":"Am J respir Crit Care Med"},{"key":"527_CR11","unstructured":"International Labour Organization (ILO) guidelines for the use of the ILO international classification of radiographs of pneumoconioses Geneva, Switzerland: ILO Publications; 2000."},{"key":"527_CR12","first-page":"261","volume":"4","author":"T Otsuki","year":"2007","unstructured":"Otsuki T, Maeda M, Murakami S, Hayashi H, Miura Y, Kusaka M, Nakano T, Fukuoka K, Kishimoto T, Hyodoh F, Ueki A, Nishimura Y: Immunological effects of silica and asbestos. Cell Mol Immunol 2007, 4: 261\u20138.","journal-title":"Cell Mol Immunol"},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/ajplung.00329.2004","volume":"288","author":"V Barbarin","year":"2005","unstructured":"Barbarin V, Xing Z, Delos M, Lison D, Huaux F: Pulmonary overexpression of IL-10 augments lung fibrosis and TH2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 2005, 288: 841\u20138. 10.1152\/ajplung.00329.2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1465-9921-6-37","volume":"6","author":"F B\u00fchling","year":"2005","unstructured":"B\u00fchling F, Wille A, Rocken C, Wiesner O, Baier A, Meinecke I, Welte T, Pap T: Altered expression of membrane-bound and soluble CD95\/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis. Respir Res 2005, 6: 37. 10.1186\/1465-9921-6-37","journal-title":"Respir Res"},{"key":"527_CR15","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1183\/09031936.00176807","volume":"32","author":"F Drakopanagiotakis","year":"2008","unstructured":"Drakopanagiotakis F, Xifteri A, Polychronopoulos V, Bouros D: Apoptosis in lung injury and fibrosis. Eur Respir J 2008, 32: 1631\u20138. 10.1183\/09031936.00176807","journal-title":"Eur Respir J"},{"key":"527_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"American Thoracic Society","year":"1995","unstructured":"American Thoracic Society. Standardization of spirometry, 1994 Update Am J Respir Crit Care Med 1995, 152: 1107\u201336.","journal-title":"Am J Respir Crit Care Med"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1183\/09041950.041s1693","volume":"6","author":"JE Cotes","year":"1993","unstructured":"Cotes JE, Chinn DJ, Quanjier PH, Roca J, Yernault JC: Standardization of the measurement of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993, 6: 41\u201352.","journal-title":"Eur Respir J"},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1164\/ajrccm.158.2.9710102","volume":"158","author":"E Bourgkard","year":"1998","unstructured":"Bourgkard E, Bernadac P, Chau N, Bertrand JP, Teculescu D, Pham Q: Can the evolution to pneumoconiosis be suspected in coal miners? A longitudinal study. Am J Respir Crit Care Med 1998, 158: 504\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"527_CR19","first-page":"96","volume":"24","author":"BJ Yuan","year":"2006","unstructured":"Yuan BJ, Liu ZZ, Ding XR, Zou JM: Levels and clinic significance of serum soluble Fas and soluble Fas ligand in coal workers' pneumoconiosis. Zhonghua Lao DongWei Sheng Zhi Ye Bing Za Zhi 2006, 24: 96\u20138. (Article in Chinese)","journal-title":"Zhonghua Lao DongWei Sheng Zhi Ye Bing Za Zhi"},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1165\/ajrcmb\/8.1.106","volume":"8","author":"K Honda","year":"1993","unstructured":"Honda K, Kimura A, Dong RP, Tamai H, Nagato H, Nishimura Y, Sasazuki T: Immunogenetic analysis of silicosis in Japan. Am J Respir Cell Mol Biol 1993, 8: 106\u201311.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"527_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1164\/ajrccm.160.supplement_1.4","volume":"160","author":"C Haslett","year":"1999","unstructured":"Haslett C: Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am J respir Crit Care Med 1999, 160: 5\u201311.","journal-title":"Am J respir Crit Care Med"},{"key":"527_CR22","first-page":"845","volume":"149","author":"RH Bardales","year":"1996","unstructured":"Bardales RH, Xie SS, Schaefer RF, Hsu SM: Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am J Pathol 1996, 149: 845\u201352.","journal-title":"Am J Pathol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-15-S2-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2047-783X-15-S2-60\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2047-783X-15-S2-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T02:52:14Z","timestamp":1576032734000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/2047-783X-15-S2-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,4]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/2047-783x-15-s2-60","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,4]]},"article-number":"60"}}